| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-07 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.23 | 3e-06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 3e-05 |